oxazoles has been researched along with Hypoglycemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andjelkovic, M; Buse, JB; Durrwell, L; El Azzouzi, B; Henry, RR; Herz, M; Jaekel, K; Mingrino, R; Wu, H | 1 |
| Bengus, M; Califf, R; Ditmarsch, M; Erdmann, E; Gerstein, HC; Malmberg, K; Ruilope, L; Schwartz, GG; Svensson, A; Volz, D; Wedel, H | 1 |
| Hasselblatt, A; Poser, W; Schwabe, U | 1 |
| Tettenborn, D | 1 |
| Loubatières, AL; Loubatières-Mariani, MM; Ribes, G | 1 |
| Blickens, DA; Riggi, SJ | 1 |
2 trial(s) available for oxazoles and Hypoglycemia
| Article | Year |
|---|---|
Efficacy, safety and tolerability of aleglitazar in patients with type 2 diabetes: pooled findings from three randomized phase III trials.
Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin Resistance; Lipids; Male; Metformin; Middle Aged; Oxazoles; Sulfonylurea Compounds; Thiophenes | 2015 |
Effects of the dual peroxisome proliferator-activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetes.
Topics: Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Diabetes Mellitus, Type 2; Double-Blind Method; Early Termination of Clinical Trials; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Middle Aged; Myalgia; Myocardial Infarction; Myositis; Oxazoles; Peripheral Arterial Disease; PPAR alpha; PPAR gamma; Prediabetic State; Stroke; Thiophenes; Treatment Outcome | 2015 |
4 other study(ies) available for oxazoles and Hypoglycemia
| Article | Year |
|---|---|
[The blood sugar lowering effect of sulfafurazole and sulfamethoxazole in the rat].
Topics: Animals; Diabetes Mellitus, Experimental; Fatty Acids, Nonesterified; Hepatectomy; Hypoglycemia; Male; Oxazoles; Rats; Sulfamethoxazole; Sulfisoxazole; Tolbutamide | 1969 |
[The toxicology of glisoxepide, a new oral antidiabetic. Results of animal studies].
Topics: Abnormalities, Drug-Induced; Administration, Oral; Animals; Azepines; Blood Glucose; Body Weight; Cats; Depression, Chemical; Dogs; Drug Evaluation, Preclinical; Female; Fertility; Glucose Tolerance Test; Hypoglycemia; Hypoglycemic Agents; Injections, Intravenous; Lethal Dose 50; Mice; Neoplasms; Oxazoles; Pregnancy; Rabbits; Rats; Seizures; Sulfonylurea Compounds; Time Factors | 1974 |
[Effect of glycemia level on insulin secretion caused by an hypoglycemic sulfamide (glisoxepide) in dogs].
Topics: Animals; Azepines; Blood Glucose; Dogs; Duodenum; Glucose; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Oxazoles; Pancreas; Radioimmunoassay; Sulfonylurea Compounds | 1972 |
Carbohydrate metabolism in normal and hyperglycemic animals treated with 1-methyl-4-(3-methyl-5-isoxazolyl)pyridinium chloride and phenformin.
Topics: Animals; Blood Glucose; Carbamates; Carbohydrate Metabolism; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Models, Animal; Fasting; Glucosamine; Glycogen; Glycosuria; Guinea Pigs; Hyperglycemia; Hypoglycemia; Lactates; Liver Glycogen; Male; Mice; Nitroso Compounds; Obesity; Oxazoles; Phenformin; Pyridinium Compounds; Rats | 1971 |